Journey Medical CEO to speak at investor conferences in September 2025.

Journey Medical Corporation announced that Claude Maraoui, CEO, will participate in two investor conferences in September 2025. Maraoui will participate in a fireside chat and 1x1 meetings at the H.C. Wainwright 27th Annual Global Investment Conference on September 8 and at the Lake Street Capital Markets 9th Annual Best Ideas Growth (BIG9) Conference on September 11. Journey Medical is a commercial-stage pharmaceutical company focused on dermatological conditions.

Journey Medical Corporation (Nasdaq: DERM), a commercial-stage pharmaceutical company focused on dermatological conditions, has announced that Claude Maraoui, Co-Founder, President, and Chief Executive Officer, will participate in two September 2025 investor conferences. Maraoui will engage in a fireside chat and 1x1 meetings at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, and at the Lake Street Capital Markets 9th Annual Best Ideas Growth (BIG9) Conference on September 11, both in New York City.

Journey Medical markets eight branded FDA-approved prescription drugs for treating common skin conditions. The company, located in Scottsdale, Arizona, was founded by Fortress Biotech, Inc. (Nasdaq: FBIO) and is known for its efficient sales and marketing model. The company's products include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend, as well as two authorized generic products, sulconazole nitrate cream and solution, and doxycycline hyclate immediate release 50mg tablets.

The participation in these conferences is an opportunity for investors and financial professionals to gain insights into the company's strategies, market position, and future growth prospects. Maraoui's involvement underscores Journey Medical's commitment to transparency and engagement with its stakeholders.

References:
[1] https://www.globenewswire.com/news-release/2025/09/03/3143630/0/en/Journey-Medical-Corporation-to-Participate-in-September-2025-Investor-Conferences.html
[2] https://www.stocktitan.net/news/DERM/journey-medical-corporation-to-participate-in-september-2025-elhqiebx3t5p.html
[3] https://ir.journeymedicalcorp.com/new-events/press-releases/detail/95/journey-medical-corporation-to-participate-in-september
[4] https://www.marketscreener.com/news/journey-medical-corp-may-sell-3-750-000-shares-of-common-stock-ce7c50dcda8df121